CCO Infectious Disease Podcast
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
- Update frequency
- every 3 days
- Average duration
- 25 minutes
- Episodes
- 461
- Years Active
- 2020 - 2025
If Treatment Supply Is Limited in Future COVID-19 Viral Peaks, How Do We Ethically Prioritize Patients for Treatment?
Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how to ethically prioritize patients for COVID-19 treatment when treatment supplies may b…
Promoting Meningococcal Vaccine Equity in Adolescent Patients
In this episode, Tamera Coyne-Beasley, MD, MPH, discusses strategies to address barriers to improve meningococcal vaccination rates by addressing social determinants of health and minimizing vaccine …
Will New COVID-19 Vaccines Affect Risk Stratification?
Fernando Carnavali, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how new COVID-19 vaccines may affect risk stratification, including:
- Omicron-specific vaccine
- Role of vaccination …
The Future of Long-Acting HIV Care: What’s Still Needed
In this episode, an international expert panel shares their thoughts on what will be needed from future long-acting HIV treatment and prevention strategies to address populations who are not eligibl…
Improving Access and Acceptance of HIV PrEP for People Who Inject Drugs
In this episode, Carolyn Chu, MD, MSc, FAAFP, AAHIVS, discusses improving HIV pre-exposure prophylaxis accessibility and availability for PWID, including by:
- Integrating PrEP with services that PWID a…
Answering the Questions on Monkeypox in PWH
In this episode, Monica Gandhi, MD, MPH, and Chloe Orkin, MBChB, FRCP, MD, discuss considerations for monkeypox, now called mpox, in people with HIV, including:
- The history of monkeypox (mpox)
- The curr…
Answering the Questions on Considering an ART Switch During Pregnancy
In this episode, Annette Haberl, MD, and William R. Short, MD, MPH, AAHIVS, discuss when to consider an ART switch during pregnancy, including:
- Current DHHS, EACS, WHO, BHIVA, and German/Austrian guid…
Expanding Access to Long-Acting ART in Europe
In this episode, Stephane De Wit, MD, PhD, discusses the benefits of long-acting antiretroviral therapy (ART) for migrant populations in Europe—and specifically in Belgium. He also addresses some of …
Whom to Screen for Hepatitis Delta Virus
In this episode, Nancy Reau, MD, and Coleman I. Smith, MD, discuss the burden of undiagnosed hepatitis delta virus (HDV) infection and who should be tested, including:
- Epidemiology of HDV infection
- Cli…
Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?
When it comes to managing adults with HBV, should age factor into your treatment decision—or is it important to treat everyone, regardless of age?
Listen as Dr George Lau discusses these questions and…
What Patients Want in HIV Treatment and Prevention: Africa
In this episode, Winnie Sseruma and Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discuss some of the barriers to genuinely patient-centered HIV care in Africa and offer calls to action for hea…
Addressing ART Safety and Tolerability in Transgender Individuals
In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:
- Strategies on…
What Patients Want in HIV Treatment and Prevention: Malaysia
In this episode, Iskandar Azwa, MBChB, and patient advocate Andrew Tan Tze Tho discuss barriers to genuinely patient-centered HIV care in Malaysia and the surrounding region and offer calls to action…
Newest Viral Hepatitis Data From AASLD 2022
In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:
- Hepatitis B
- Prevention of HBV vertical transmission when HBIg is unavailable
- Therapeutic vaccination fo…
Practice-Changing Viral Hepatitis Data From AASLD 2022
In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:
- Novel therapeutics for HBV
- HCV management strategies
- HDV screening and…
FAQs: Improving Empiric Antibiotic Regimens for HABP/VABP in the ICU
In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with …
Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Audio Recap
In this episode, Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, discuss new HIV data presented at IDWeek and HIV Glasgow 2022, including
- Prevention strategies
- LA therapies
- Investigational agen…
COVID-19 Antiviral Agents and COVID-19 Rebound
In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, inclu…
Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap
In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:
- COVID-19 vaccines, including omicron BA.1 bivalent booster
- Risk factors for breakthroug…
Creative Strategies for Meningococcal Vaccine Uptake
In this episode, Nneka Holder, MD, MPH, shares various strategies to improve meningococcal vaccine uptake in adolescent patients, including:
- Use of school vaccine mandates beyond entry requirements
- Pr…